ALFA Filings
Every announcement, straight from the exchange
Every Asston Pharmaceuticals capital structure change announcement on NSE and BSE, newest first, each with its own page.
Time
3 announcements with these filters
The company submitted a revised shareholding pattern following the allotment of 24,10,431 equity shares through a preferential allotment dated September 5, 2026.
Asston Pharmaceuticals allotted 24,10,431 equity shares at Rs. 115 per share via preferential allotment, raising Rs. 27.72 Crore. This increases the company's paid-up equity share capital.
Prakruti R Pali acquired 2,40,000 shares of Asston Pharmaceuticals Ltd through an open market purchase. Post-acquisition stake is 5.33%.